KOURTNEY RUSSO: Open Payments
NPI 1487207031 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,368 in 95 payments from 35 companies in 2025. Trend: 2023 $2,147 · 2024 $2,924 · 2025 $2,368
Food & beverage: $2,368
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $224 |
| Daiichi Sankyo Inc. | 12 | $217 |
| Kite Pharma, Inc. | 5 | $177 |
| Janssen Biotech, Inc. | 3 | $155 |
| Sirtex Medical Inc | 1 | $147 |
| ABBVIE INC. | 6 | $133 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $100 |
| Incyte Corporation | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
Products named: Yescarta, REBLOZYL, SIR-Spheres Microspheres, OJJAARA, RYBREVANT, ZYNLONTA, DATROWAY, Enhertu.
Industry payments across TX — which companies pay providers there.
